Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.13M Buy
55,485
+1,124
+2% +$204K 0.67% 45
2026
Q1
$8M Buy
54,361
+14,305
+36% +$2.33M 0.76% 46
2025
Q4
$7.81M Sell
40,056
-374
-0.9% -$89K 0.73% 46
2025
Q3
$11.4M Buy
40,430
+20,575
+104% +$5.24M 1.13% 28
2025
Q2
$4.34M Sell
19,855
-492
-2% -$79.4K 0.47% 53
2025
Q1
$2.84M Sell
20,347
-10
-0% -$1.63K 0.36% 57
2024
Q4
$3.39M Buy
20,357
+2,140
+12% +$380K 0.42% 52
2024
Q3
$2.29M Sell
18,217
-2,380
-12% -$345K 0.33% 58
2024
Q2
$2.91M Buy
20,597
+2,370
+13% +$294K 0.4% 51
2024
Q1
$2.29M Buy
18,227
+10,893
+149% +$1.25M 0.33% 58
2023
Q4
$773K Buy
7,334
+86
+1% +$9.39K 0.12% 100
2023
Q3
$768K Hold
7,248
0.14% 99
2023
Q2
$863K Buy
+7,248
New +$749K 0.15% 91

Other funds holding ORCL

Nemes Rush Group's ORCL Position: Q2 2026 in Review

Nemes Rush Group increased its Oracle (ORCL) stake by 2.1% in Q2 2026, buying an estimated $204K and bringing the position to 55,485 shares worth $8.13M. The position accounts for 0.67% of the portfolio, ranked #45.

Nemes Rush Group first reported a position in ORCL in Q2 2023 and has held it in 13 quarters since. The position peaked at $11.4M in Q3 2025. 3,524 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Nemes Rush Group held 55,485 shares of Oracle worth $8.13M as of Q2 2026.
  • Nemes Rush Group bought 1,124 Oracle shares in Q2 2026, an estimated $204K.
  • Oracle made up 0.67% of Nemes Rush Group's portfolio in Q2 2026, its #45 holding.
  • Nemes Rush Group first reported a position in Oracle in Q2 2023 and has held it in 13 quarters since.
  • Nemes Rush Group's Oracle position peaked at $11.4M in Q3 2025.
  • 3,524 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.